222 related articles for article (PubMed ID: 2190313)
21. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
22. Cyclosporine trials in diabetes: updated results of the French experience.
Assan R; Feutren G; Sirmai J
Transplant Proc; 1988 Jun; 20(3 Suppl 4):178-83. PubMed ID: 3289203
[No Abstract] [Full Text] [Related]
23. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
Ferrari P; Frey FJ
Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
[TBL] [Abstract][Full Text] [Related]
24. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
25. Bromocriptine in rheumatic and autoimmune diseases.
McMurray RW
Semin Arthritis Rheum; 2001 Aug; 31(1):21-32. PubMed ID: 11503136
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppressive treatment of Graves' ophthalmopathy with cyclosporine A.
Utech C; Wulle KG; Panitz N; Kiefer H
Transplant Proc; 1988 Jun; 20(3 Suppl 4):173-7. PubMed ID: 3381272
[No Abstract] [Full Text] [Related]
27. Cyclosporine therapy for autoimmune disease.
Fathman CG; Myers BD
N Engl J Med; 1992 Jun; 326(25):1693-5. PubMed ID: 1588984
[No Abstract] [Full Text] [Related]
28. [Immunosuppressive therapy].
Purice S
Stud Cercet Med Interna; 1973; 14(3):209-16. PubMed ID: 4574134
[No Abstract] [Full Text] [Related]
29. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
[TBL] [Abstract][Full Text] [Related]
30. Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders.
Namazi MR
Int Immunopharmacol; 2004 Mar; 4(3):349-53. PubMed ID: 15037212
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
Schluep M; Steck AJ; Despland PA; Regli F; Ochsner F; Berrut E; Gauthier G
Schweiz Rundsch Med Prax; 1991 Jun; 80(24):670-2. PubMed ID: 2068440
[TBL] [Abstract][Full Text] [Related]
32. [Successful treatment of primary biliary cirrhosis with cyclosporin].
Lie TS; Preissinger H
Dtsch Med Wochenschr; 1990 May; 115(18):698-702. PubMed ID: 2335133
[TBL] [Abstract][Full Text] [Related]
33. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
Meyrier A; Simon P
Adv Nephrol Necker Hosp; 1988; 17():127-50. PubMed ID: 3124536
[TBL] [Abstract][Full Text] [Related]
34. [Induction of remissions of insulin-dependent diabetes by cyclosporin].
Feutren G; Papoz L; Assan R; Vialettes B; Pehuet M; Vexiau P; Durostu H; Rodier M; Sirmai J; Lallemand A
C R Acad Sci III; 1986; 303(8):295-7. PubMed ID: 3094846
[TBL] [Abstract][Full Text] [Related]
35. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review.
Atzeni F; Sarzi-Puttini P; Doria A; Iaccarino L; Capsoni F
Autoimmun Rev; 2005 Mar; 4(3):144-52. PubMed ID: 15823500
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
Kappos L; Patzold U; Dommasch D; Poser S; Haas J; Krauseneck P; Malin JP; Fierz W; Graffenried BU; Gugerli US
Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
[TBL] [Abstract][Full Text] [Related]
37. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
[TBL] [Abstract][Full Text] [Related]
38. Management of patients and side effects during cyclosporine therapy for cutaneous disorders.
Fradin MS; Ellis CN; Voorhees JJ
J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1265-73; discussion 1273-5. PubMed ID: 2277134
[TBL] [Abstract][Full Text] [Related]
39. [Cyclosporin-A therapy in autoimmune diseases].
Patakfalvi A
Orv Hetil; 1996 Sep; 137(35):1921-7. PubMed ID: 8927346
[TBL] [Abstract][Full Text] [Related]
40. Sandimmun(®) (ciclosporin, Cyclosporin A) Past experience and present uses in autoimmune diseases.
Wiskott E
Ocul Immunol Inflamm; 1993; 1(3):187-94. PubMed ID: 22822772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
